Unichem Laboratories : Certificate under regulation 74(5) of the SEBl (Depositories and Participants) Regulations. 2018 for the quarter ended December 31, 2020.
January 14, 2021 at 08:44 am
Share
January , 2021
The Secretary
The Manager
Listing Department
Listing Department
Bombay Stock Exchange Ltd.
National Stock Exchange of India Ltd
Phiroze Jeejeebhoy Towers,
Exchange Plaza, Bandra - Kurla Complex
Dalal Street,
Bandra (East), Mumbai - 400 051
Mumbai- 400 001
Scrip Code -506690
Stock Symbol - UNICHEMLAB
Dear Sir/Madam,
Sub: Compliance Certificate under regulation 74[5) of the SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended December 31, 2020.
We are enclosing herewith a certificate dated October 7, 2020 issued by Link Intime India Pvt. Ltd., Registrar & Share Transfer Agent of Company confirming compliance with Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended December 31, 2020.
Unichem Laboratories Ltd. published this content on 13 January 2021 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 14 January 2021 08:43:08 UTC
Unichem Laboratories Limited is an India-based international, integrated, specialty pharmaceutical company. The Company is focused on product development, process chemistry and manufacturing complex active pharmaceutical ingredients (API) as well as dosage forms. It manufactures and markets pharmaceutical formulations as branded generics as well as generics in several markets across the world. It has several pharma products that address the needs of various therapeutic areas, such as gastroenterology, cardiology, diabetology, psychiatry, neurology, anti-bacterial, anti-infectives and pain management. The Company is also engaged in contract manufacturing with the focus on immediate-release dosage forms, extended-release dosage forms: matrix and pellets, dry powder injections and syrups, novel drug delivery systems, and technology transfer and documentation. Its subsidiaries include Unichem Pharmaceuticals (USA) Inc, Unichem Farmaceutica Do Brasil Lta and Niche Generics Limited UK.
Unichem Laboratories : Certificate under regulation 74(5) of the SEBl (Depositories and Participants) Regulations. 2018 for the quarter ended December 31, 2020.